drugset / Trial / NCT02386839
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the long-term efficacy and safety outcomes following short-term exposure to rhIGF-1/rhIGFBP-3 versus standard neonatal care in Study ROPP-2008-01 (NCT01096784).
Timeline
- Start
- 2015-03-26
- Primary completion
- 2021-09-28
- Completion
- 2021-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhIGF-1/rhIGFBP-3 | Unknown | — | — |